GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Baskhanbiopharma Inc (XKRX:354390) » Definitions » Cash Flow for Lease Financing

Baskhanbiopharma (XKRX:354390) Cash Flow for Lease Financing : ₩-260 Mil (TTM As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Baskhanbiopharma Cash Flow for Lease Financing?

Baskhanbiopharma's Cash Flow for Lease Financing for the six months ended in Dec. 2024 was ₩-260 Mil. Baskhanbiopharma's Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Dec. 2024 was ₩-260 Mil.

Compared with last quarter (₩-313 Mil in Dec. 2023 ), Baskhanbiopharma's Cash Flow for Lease Financing increased in Dec. 2024 (₩-260 Mil).

Baskhanbiopharma Cash Flow for Lease Financing Historical Data

The historical data trend for Baskhanbiopharma's Cash Flow for Lease Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Baskhanbiopharma Cash Flow for Lease Financing Chart

Baskhanbiopharma Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Cash Flow for Lease Financing
-66.96 -148.78 -274.46 -312.55 -259.89

Baskhanbiopharma Semi-Annual Data
Dec20 Dec21 Dec22 Dec23 Dec24
Cash Flow for Lease Financing -66.96 -148.78 -274.46 -312.55 -259.89

Baskhanbiopharma Cash Flow for Lease Financing Calculation

Cash Flow for Lease Financing is change in cash flow resulting from increase or decrease in lease financing.


For stock reported annually, GuruFocus uses latest annual data as the TTM data. Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Dec. 2024 was ₩-260 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Baskhanbiopharma Cash Flow for Lease Financing Related Terms

Thank you for viewing the detailed overview of Baskhanbiopharma's Cash Flow for Lease Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

Baskhanbiopharma Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Baskhanbiopharma Inc (XKRX:354390) » Definitions » Cash Flow for Lease Financing
Comparable Companies
XKRX:018620 XKRX:318010 XKRX:034940 XKRX:233250 XKRX:336040 XKRX:018680 XKRX:900120 XKRX:053950 XKRX:200230 XKRX:314140 ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
N/A
Address
354 Wondang-ro, Wongok-myeon, Anseong-si, Gyeonggi-do, KOR
Website
https://www.baskhanbio.com
Baskhanbiopharma Inc manufactures and distributes prescription drugs, over the counter drugs, medical devices and other related products.

Baskhanbiopharma Headlines

No Headlines